Also called: Semax + Hopantenic acid combination, Semax + Epitalon, Semax + BPC-157
Semax is a man-made substance that acts like a small protein in the body. It is based on a natural hormone but is changed to last longer and work better. Scientists study it to see how it affects the brain and nervous system. It is mostly used by researchers looking into memory, focus, and how the brain handles stress. It is not a medicine you can buy at a store, and it is mostly for lab use only.
The main reason researchers look at Semax is for its possible effects on the brain. Studies suggest it might help the brain work faster and stay clear under stress. It seems to work by helping brain cells talk to each other and stay healthy. Some research looks at how it might protect the brain from damage. It is also being studied to see if it helps people recover from strokes or injuries to the nervous system.
There is still a lot we do not know about Semax for sure. Most of the proof comes from animal studies, not large tests with people. Because of this, we cannot be certain it is safe or works the same way in humans. There are also rules about who can make and sell it. In the United States, a group of experts voted to allow special pharmacies to make it, but the government has not made a final decision yet. You should be careful because it is not officially approved for general use.
Semax is an approved medicine in Russia for ischemic stroke, cognitive and neurological indications; it is not approved by the US FDA or the EMA. On July 24, 2026, PCAC voted 8–5 to recommend adding Semax to the Section 503A Bulks List. The recommendation is advisory only — FDA rulemaking (typically 12–24 months) must conclude before any change in legal status. Semax is not on the 503A Bulks List, remains an unapproved new drug, and may not be lawfully compounded by traditional 503A pharmacies in the interim.
Benefits
The main themes across 30 research studies, in plain language.
Research suggests potential benefits for enhancing memory, attention, learning speed, and overall cognitive performance.
Studies indicate potential to support neurological recovery and protect brain tissue following stroke, trauma, or ischemia.
Research indicates it may stimulate the production of key proteins like BDNF and NGF that support neuron growth and survival.
Evidence suggests it may modulate stress pathways and neurotransmitters to reduce anxiety without causing sedation.
Research points to effects on dopamine, serotonin, and GABA systems that may influence brain function and behavior.
Studies suggest it may help protect brain cells from oxidative stress, inflammation, and toxic proteins like amyloid-beta.
Research suggests potential protective effects for the optic nerve and treatment of pathologies like glaucoma.
Evidence suggests potential to protect the stomach lining and support the integrity of the intestinal barrier.
Research suggests potential to regulate immune response genes and reduce pro-inflammatory mediators.
Studies suggest it may influence gene expression profiles and markers associated with aging, such as telomerase activity.
Preliminary research indicates potential roles in supporting mitochondrial health and cellular bioenergetics.
You just read the research on Semax. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
2 reported routines — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
Self-reported & vendor-suggested
Routines shared by users and sellers in forums and product pages — anecdotal, not tested in clinical trials. We show them for completeness, not as a recommendation.
General
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Evidence
Every claim above traces back to a source you can check — here are 31 of them.
Effect of semax on the temporary dynamics of brain-derived neurotrophic factor and nerve growth factor gene expression in the rat hippocampus and frontal cortex
A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)
Semax and selank inhibit the enkephalin-degrading enzymes from human serum]
Neuroprotective and antiamnesic effects of Semax during experimental ischemic infarction of the cerebral cortex.
Semax and selank inhibit the enkephalin-degrading enzymes from human serum]
N-terminal degradation of ACTH(4-10) and its synthetic analog semax by the rat blood enzymes.
Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone
Therapy of peptic ulcer with semax peptide.
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus.
Effects of Semax on dopaminergic and serotoninergic systems of the brain.
Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.
Effects of chronic Semax administration on exploratory activity and emotional reaction in white rats
Heptapeptide semax attenuates the effects of chronic unpredictable stress in rats.
Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats.
Therapeutic possibility of "Semax" for depression
Timeline
Key moments in Semax’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions Semax.
A November 2025 New York Times explainer takes a skeptical consumer lens to the peptide-therapy craze, separating the few uses with reasonable evidence (topical GHK-Cu and Matrixyl-type peptides in skincare) from the largely unproven injectable and "biohacking" market (BPC-157, TB-500, epitalon, semax, selank). Dermatologists frame cosmetic peptides as "sidekicks, not hero ingredients," while endocrinologists warn that growth-hormone-releasing peptides like sermorelin and tesamorelin carry the same long-term risks as HGH — diabetes, certain cancers, and acromegaly. The piece notes that most longevity claims rest on cell-culture or animal data only, and that "research-grade" products have no quality controls.
On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee recommended adding six of seven reviewed peptides (BPC-157, KPV, TB-500, MOTS-c, Epitalon, Semax) to the Section 503A Bulks List and rejected Emideltide/DSIP. The vote is advisory only — not a final FDA decision and not legal authorization to compound. FDA must still complete formal notice-and-comment rulemaking (typically 12–24 months) before any change in legal status.
Wondering how Semax pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.